Article Information
PubMed
Published By
History
- Received April 29, 2013
- Revision received February 13, 2014
- Accepted March 10, 2014
- First published April 30, 2014.
- Version of record published April 30, 2014.
Copyright & Usage
Copyright © 2014 the authors 0270-6474/14/346273-13$15.00/0
Author Information
- Andrew Sharott1,2,
- Alessandro Gulberti1,
- Simone Zittel3,4,
- Adam A. Tudor Jones2,
- Ulrich Fickel1,
- Alexander Münchau3,4,
- Johannes A. Köppen5,
- Christian Gerloff3,
- Manfred Westphal5,
- Carsten Buhmann3,
- Wolfgang Hamel5,
- Andreas K. Engel1, and
- Christian K.E. Moll1
- 1Department of Neurophysiology and Pathophysiology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany,
- 2Medical Research Council Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom,
- 3Department of Neurology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany,
- 4Department of Pediatric and Adult Movement Disorders and Neuropsychiatry, Institute of Neurology, University Medical Center Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany, and
- 5Department of Neurosurgery, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany
Author contributions
Author contributions: A.S., A.M., C.G., M.W., W.H., A.K.E., and C.K.E.M. designed research; A.S., A.G., S.Z., J.A.K., C.B., W.H., and C.K.E,M. performed research; A.S., A.A.T.J., and U.F. analyzed data; A.S. and C.K.E.M. wrote the paper.
Disclosures
- Received April 29, 2013.
- Revision received February 13, 2014.
- Accepted March 10, 2014.
This work was supported by grants from the European Union (MRTN-CT-2005-019247 to A.K.E, FP7-ICT-270212 to A.K.E. and A.G., and Marie Curie European Re-integration Grant SNAP-PD to A.S.; Medical Research Council, UK (award U138197109, A.S.); and the Deutsche Forschungsgemeinschaft (SFB 936 to A.M., C.G., and A.K.E.). We are grateful to Peter Brown for valuable scientific discussions.
The authors declare no competing financial interests.
- Correspondence should be addressed to either of the following: Dr. Andrew Sharott, Medical Research Council Anatomical Neuropharmacology Unit, University of Oxford, Oxford OX1 3TH, United Kingdom, andrew.sharott{at}pharm.ox.ac.uk; or Dr. Christian Moll, Department of Neurophysiology and Pathophysiology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany, c.moll{at}uke.uni-hamburg.de
Online Impact